These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Rejection of a liver allograft. Diagnosis and treatment]. Calmus Y Ann Radiol (Paris); 1994; 37(5):377-82. PubMed ID: 7527621 [TBL] [Abstract][Full Text] [Related]
4. Successful living donor kidney transplantation across HLA and ABO incompatibilities. Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704 [No Abstract] [Full Text] [Related]
5. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216 [No Abstract] [Full Text] [Related]
6. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants. Fryer JP; Benedetti E; Perry EH; Matas AJ Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694 [No Abstract] [Full Text] [Related]
7. ABO incompatible liver transplantation: a case of immediate need. Srinivas Reddy M; Wilson C; Torpey N; Manas DM Transpl Int; 2007 Oct; 20(10):904-5. PubMed ID: 17630997 [No Abstract] [Full Text] [Related]
8. The influence of HLA and ABO antigens on graft rejection and survival. Sanfilippo F Clin Lab Med; 1991 Sep; 11(3):537-50. PubMed ID: 1934964 [TBL] [Abstract][Full Text] [Related]
9. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression. Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483 [No Abstract] [Full Text] [Related]
10. Adult ABO-incompatible liver transplantation, using A and B donors. Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811 [TBL] [Abstract][Full Text] [Related]
11. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine. Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466 [No Abstract] [Full Text] [Related]
12. Progress in understanding humoral rejection in kidney transplantation: implications for patient management. Pascual MA; Crespo M; Tolkoff-Rubin N Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504 [TBL] [Abstract][Full Text] [Related]
13. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection. Levey AS Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406 [TBL] [Abstract][Full Text] [Related]
14. FK 506 rescue therapy: early conversion improves efficacy. Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359 [No Abstract] [Full Text] [Related]